Paul Clancy
2019
In 2019, Paul Clancy earned a total compensation of $5.9M as Executive Vice President, Senior Advisor and Former Chief Financial Officer at Alexion Pharmaceuticals, a 7% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $1,051,218 |
|---|---|
| Salary | $927,000 |
| Stock Awards | $3,863,694 |
| Other | $23,832 |
| Total | $5,865,744 |
Clancy received $3.9M in stock awards, accounting for 66% of the total pay in 2019.
Clancy also received $1.1M in non-equity incentive plan, $927K in salary and $23.8K in other compensation.
Rankings
In 2019, Paul Clancy's compensation ranked 1,770th out of 13,971 executives tracked by ExecPay. In other words, Clancy earned more than 87.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,770 out of 13,971 | 87th |
Division Manufacturing | 629 out of 5,692 | 89th |
Major group Chemicals And Allied Products | 189 out of 2,189 | 91st |
Industry group Drugs | 152 out of 1,875 | 92nd |
Industry Pharmaceutical Preparations | 114 out of 1,387 | 92nd |
Source: SEC filing on March 26, 2020.
Clancy's colleagues
We found five more compensation records of executives who worked with Paul Clancy at Alexion Pharmaceuticals in 2019.
2019
Ludwig Hantson
Alexion Pharmaceuticals
Chief Executive Officer
2019
John Orloff
Alexion Pharmaceuticals
Executive Vice President, Head of Research and Development
2019
Brian Goff
Alexion Pharmaceuticals
Executive Vice President, Chief Commercial and Global Operations Officer
2019
Anne-Marie Law
Alexion Pharmaceuticals
Executive Vice President, Chief Human Experience Officer
2019
Aradhana Sarin
Alexion Pharmaceuticals